Reply to thread

many clearly don't understand who is currently responsible for Tildra's submission. This is now Merck's drug and they are responsible for filing.  Sun takes ownership upon approval. There's a talented team there and they're working hard building a culture and making moves to establish a significant Derm organization with multiple assets across the specialty.